Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Sale and Maturity of Investments (2018 - 2026)

Updated

Abeona Therapeutics' Sale and Maturity of Investments - Total came in at $50.02 million for Q3 2026, up 30.8% from $38.24 million a year earlier and up 22.4% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Sale and Maturity of Investments (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Abeona Therapeutics reported Sale and Maturity of Investments - Total of $164.28 million, up 10.4% year-over-year; for FY2025, it was $319.64 million, up 165.9% from FY2024.

  • Sale and Maturity of Investments - Total carries a five-year compound annual growth rate of 29.4% (FY2020 to FY2025).
  • Going back by year, Sale and Maturity of Investments - Total was $120.2 million in FY2024 (+131.3%), $51.97 million in FY2023 (-1.3%), $52.64 million in FY2022 (-41.8%) and $90.38 million in FY2021 (+2.6%).
  • The Q3 2026 figure represents the highest quarterly Sale and Maturity of Investments - Total since Q1 2025.
  • Year-over-year, Sale and Maturity of Investments - Total increased in six of the last eight quarters, with growth averaging 45.9%.
  • The fastest year-over-year change in Sale and Maturity of Investments - Total over five years came in Q3 2024 (growth of 231.3%), and the weakest in Q1 2022 (a decline of 65.3%).
  • Business Quant data shows ABEO's Sale and Maturity of Investments - Total at $40.87 million (Q2 2026), $24.9 million (Q1 2026) and $48.49 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 308.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - 88.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 2.53 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn 50.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 50.02 Mn
Jun 30, 2026 40.87 Mn
Mar 31, 2026 24.90 Mn
Dec 31, 2025 48.49 Mn
Sep 30, 2025 38.24 Mn
Jun 30, 2025 26.28 Mn
Mar 31, 2025 54.26 Mn
Dec 31, 2024 29.97 Mn
Sep 30, 2024 50.87 Mn
Jun 30, 2024 17.11 Mn
Mar 31, 2024 22.25 Mn
Dec 31, 2023 14.97 Mn
Sep 30, 2023 15.36 Mn
Jun 30, 2023 11.26 Mn
Mar 31, 2023 10.39 Mn
Dec 31, 2022 8.94 Mn
Sep 30, 2022 10.97 Mn
Jun 30, 2022 24.07 Mn
Mar 31, 2022 8.67 Mn
Dec 31, 2021 16.25 Mn
API Access

Abeona Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ABEO&period=max&api_key=YOUR_API_KEY